A5057057365- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiac electrophysiology and arrhythmias
- Cardiomyopathy and Myosin Studies
- Cardiovascular Effects of Exercise
- Cardiovascular Syncope and Autonomic Disorders
- Ion channel regulation and function
- Neurological disorders and treatments
- Cardiac Valve Diseases and Treatments
- Acute Ischemic Stroke Management
- Advanced MRI Techniques and Applications
- Streptococcal Infections and Treatments
- Venous Thromboembolism Diagnosis and Management
- Electron Spin Resonance Studies
- Cardiovascular Function and Risk Factors
- Infective Endocarditis Diagnosis and Management
- Blood Pressure and Hypertension Studies
- Antimicrobial Resistance in Staphylococcus
- Trypanosoma species research and implications
Hospital Privado
2015-2024
Centro Científico Tecnológico - Bahía Blanca
2007-2019
Universitat de Barcelona
2018
Kleijnen Systematic Reviews (United Kingdom)
2018
Bristol-Myers Squibb (Germany)
2018
Hospital Sant Joan de Déu Barcelona
2018
American College of Cardiology
2016
Ministero della Salute
2002
Meyer Children's Hospital
2002
Ministério da Saúde
2002
The current manuscript is the second update of original Practical Guide, published in 2013 [Heidbuchel et al. European Heart Rhythm Association Guide on use new oral anticoagulants patients with non-valvular atrial fibrillation. Europace 2013;15:625-651; Heidbuchel Updated non-vitamin K antagonist 2015;17:1467-1507]. Non-vitamin (NOACs) are an alternative for vitamin antagonists (VKAs) to prevent stroke fibrillation (AF) and have emerged as preferred choice, particularly newly started...
Background — Mutations in the cardiac ryanodine receptor gene ( RyR2 ) underlie catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited arrhythmogenic disease occurring structurally intact heart. The proportion of patients with CPVT carrying mutations is unknown, and clinical features -CPVT as compared nongenotyped are undefined. Methods Results Patients documented arrhythmias during physical or emotional stress a normal heart entered study. phenotype 30 probands 118...
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective for selected patients in definable populations. The benefits and risks of ICD are directly impacted by programming surgical decisions. This flexibility both a great strength weakness, which there has been no prior official discussion or guidance. It the consensus four continental electrophysiology societies that important clinical issues sufficient trial data to provide evidence-based expert document systematically...
Abstract The 2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing provided guidance bradycardia programming, tachycardia detection, therapy, defibrillation testing for implantable cardioverter-defibrillator (ICD) patient treatment. 32 recommendations represented the consensus opinion of writing group, graded by Class Recommendation Level Evidence. In addition, Appendix B manufacturer-specific translations these into...
<h3>Importance</h3> Patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) may experience life-threatening arrhythmic events (LTAEs) despite β-blocker treatment. Further complicating management, the role of implantable cardioverter defibrillator (ICD) in CPVT is debated. <h3>Objective</h3> To investigate long-term outcomes patients with<i>RYR2</i>CPVT treated β-blockers only and cost to benefit ratio ICD. <h3>Design, Settings, Participants</h3> This prospective cohort...
To assess the results of transcatheter ablation cardiac arrhythmias in Latin America and establish first American registry. All procedures performed between 1 January 31 December 2012 were analysed retrospectively. Data obtained on characteristics resources participating centres (public or private institution, number beds, surgery availability, type room for procedures, days per week assigned to electrophysiology fluoroscopy equipment, availability electroanatomical mapping system,...
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective for selected patients in definable populations. The benefits and risks of ICD are directly impacted by programming surgical decisions. This flexibility both a great strength weakness, which there has been no prior official discussion or guidance. It the consensus 4 continental electrophysiology societies that important clinical issues sufficient trial data to provide evidence-based expert document systematically...
Debate about the best clinical approach to management of asymptomatic patients with ventricular pre-excitation and advice on whether or not invasively stratify ablate is on-going. Weak evidence real risk sudden cardiac death potential benefit catheter ablation has probably prevented clarification action in this infrequent sometimes conflicting situation. After analysing all available data, evidence-based medicine could be alternative strategy for managing group patients. According recent...
This paper is an executive summary of the full European Heart Rhythm Association (EHRA) consensus document on management supraventricular arrhythmias, published in Europace . It summarises developments field and provides recommendations for patient management, with particular emphasis new advances since previous Society Cardiology guidelines. The EHRA available to read at http://europace.oxfordjournals.org
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an arrhythmo-genic cardiac disease predisposing affected individuals to sudden death (SCD). Methods and Results: Here we provide data on the largest CPVT population thus far described. The study consisted of 177 patients (64% female) 93 families. All probands (pbs) were screened for RYR2 mutations: 54 (58%) pbs carried a heterozygous mutation, 1 pb compound mutation 3 homozygous (1), (1) or CASQ2 mutation. One KCNJ2...